Asthma | Adult
Item
1. adult (over 19 years) asthma patients
boolean
C0004096 (UMLS CUI [1])
C0001675 (UMLS CUI [2])
Mild persistent asthma | Moderate persistent asthma | Severe persistent asthma
Item
2. patients who have a history of mild-to-moderate-severe, persistent asthma for at least 6 months prior to screening.
boolean
C1960046 (UMLS CUI [1])
C1960047 (UMLS CUI [2])
C1960048 (UMLS CUI [3])
FEV1 | Pharmaceutical Preparations Asthma
Item
3. patients who were required to demonstrate a fev1 of ≥ 40 % and ≤ 85% of predicted normal values during screening period following appropriate withholding of asthma medications (if applicable).
boolean
C0748133 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0004096 (UMLS CUI [2,2])
Forced Expiratory Volume in 1 Second Reversibility | Inhaled albuterol preparation
Item
4. patients who were required to show reversibility of ≥15% fev1 after salbutamol inhalation (2 actuations, 100µg per actuation) from the pre- salbutamol value at screening
boolean
C3830088 (UMLS CUI [1])
C0354688 (UMLS CUI [2])
Uncontrolled Asthma | Seretide | Asthma control test
Item
5. patients who have uncontrolled asthma by seretide® 250/50 defined as act less than 20
boolean
C0205318 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C1130494 (UMLS CUI [2])
C2733011 (UMLS CUI [3])
Small airways
Item
6. patients who showed r5-20 more than 0.1 kpa/l/s
boolean
C1862763 (UMLS CUI [1])
Eosinophil count procedure
Item
7. blood eosinophil count > 300/µl on screening visit
boolean
C0200638 (UMLS CUI [1])
Childbearing Potential | Urine pregnancy test negative
Item
8. female patients of childbearing potential must have a negative urine pregnancy test at screening.
boolean
C3831118 (UMLS CUI [1])
C0430057 (UMLS CUI [2])
Ability Use of Inhaler
Item
9. patients who are able to use the inhaler
boolean
C0085732 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0021461 (UMLS CUI [1,3])
Informed Consent
Item
10. patients who is willing to voluntarily sign the study consent form
boolean
C0021430 (UMLS CUI [1])
Asthma Life Threatening | Respiratory Tract Infections | emergency visit Asthma | Hospitalization Asthma
Item
1. patients who have experienced life-threatening asthma within 12 months prior to screening or respiratory infection within 4 weeks prior to screening, or patients who have experienced any emergency visit or hospitalization due to acute asthma symptoms within 4 weeks prior to screening
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0035243 (UMLS CUI [2])
C0553618 (UMLS CUI [3,1])
C0004096 (UMLS CUI [3,2])
C0019993 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
Disease | Lung diseases | Chronic Obstructive Airway Disease | Cystic Fibrosis | Bronchiectasis | Tuberculosis
Item
2. patients who have diagnosed as clinically significant disease or non- reversible pulmonary disease or patients who currently have active pulmonary disease (eg. copd, cystic fibrosis, bronchiectasis, active tuberculosis)
boolean
C0012634 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
C0024117 (UMLS CUI [3])
C0010674 (UMLS CUI [4])
C0006267 (UMLS CUI [5])
C0041296 (UMLS CUI [6])
Laryngitis | Chronic sinusitis | Common Cold | Allergic rhinitis | Patient Outcome - Worsening | Purulent discharge
Item
3. patients who have diagnosed as laryngitis, chronic sinusitis, infectious rhinitis or allergic rhinitis within 4 weeks prior to screening, or patients who have had any symptoms of acute exacerbation or purulent discharge by the disease above within 2 weeks prior to screening
boolean
C0023067 (UMLS CUI [1])
C0149516 (UMLS CUI [2])
C0009443 (UMLS CUI [3])
C2607914 (UMLS CUI [4])
C1546960 (UMLS CUI [5])
C0333274 (UMLS CUI [6])
Current Smoker | Former smoker
Item
4. current smoker or past smoker defined as below:
boolean
C3241966 (UMLS CUI [1])
C0337671 (UMLS CUI [2])
Current Smoker Smoking History
Item
current smoker: smoking history within 12 months prior to screening
boolean
C3241966 (UMLS CUI [1,1])
C1519384 (UMLS CUI [1,2])
Former smoker Smoking cigarettes: ____ pack-years history
Item
past smoker: smoking amount ≥10 pack year*
boolean
C0337671 (UMLS CUI [1,1])
C2230126 (UMLS CUI [1,2])
Pack years Calculation
Item
pack year (py) calculation: average amount of smoking per day (pack) x duration of smoking (year)
boolean
C1277691 (UMLS CUI [1,1])
C1441506 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
5. patients who currently are pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
systemic steroids
Item
6. patient who had taken systemic corticosteroid within 4 weeks prior to screening
boolean
C2825233 (UMLS CUI [1])
omalizumab
Item
7. patients who had taken omalizumab within 24 weeks prior to screening
boolean
C0966225 (UMLS CUI [1])
Following Pharmaceutical Preparations
Item
8. patients who had taken the following medications within 1 week prior to screening:
boolean
C0332282 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Cytochrome P-450 CYP3A Inhibitors
Item
potent cyp3a inhibitors
boolean
C3850056 (UMLS CUI [1])
Adrenergic beta-Antagonists
Item
β-blockers
boolean
C0001645 (UMLS CUI [1])
Monoamine Oxidase Inhibitors
Item
monoamine oxidase inhibitor
boolean
C0026457 (UMLS CUI [1])
Tricyclic Antidepressive Agents
Item
tca (tricyclic antidepressants)
boolean
C0003290 (UMLS CUI [1])
Anti-Arrhythmia Agents Quinidine
Item
quinidine-type anti arrhythmic
boolean
C0003195 (UMLS CUI [1,1])
C0034414 (UMLS CUI [1,2])
Leukotriene Antagonists
Item
leukotriene anatagonist
boolean
C0595726 (UMLS CUI [1])
Astemizole
Item
astemizole
boolean
C0085170 (UMLS CUI [1])
Study Subject Participation Status | Interventional Study
Item
9. patients who are participating or going to participate in any interventional clinical trials
boolean
C2348568 (UMLS CUI [1])
C3274035 (UMLS CUI [2])
Prolonged QT interval
Item
10. qt interval prolongation in ecg result at screening
boolean
C0151878 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Excipient
Item
11. patients with hypersensitive to investigational products or to any component of the drug
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0015237 (UMLS CUI [2,2])
Study Subject Participation Status Difficult
Item
12. patients who are judged difficult to participate in this investigation by the investigator
boolean
C2348568 (UMLS CUI [1,1])
C0332218 (UMLS CUI [1,2])